APRE Competitors & Alternatives
Compare Aprea Therapeutics Inc with similar stocks in the same industry
Biotechnology
APRE
Main Stock$0.98
Tradestie Score
55
Market Cap
$8.50M
Revenue Growth
-1.0%
Analyst Upside
+349.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$21.57
|
$170.45M | - | 57 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.37
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.26
|
$110.20M | - | 52 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$40.24
|
$76.55M | - | 63 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$1.49
|
$72.18M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$7.32
|
$71.69M | - | 60 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.75
|
$67.94M | - | 55 | Compare |
|
CYCN
Cyclerion Therapeutics, Inc. Common Stock
|
$3.10
|
$7.59M | - | 50 | Compare |
|
GRTX
GRTX
|
- | - | - | - | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More APRE Analysis
Data updated: May 10, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry